Cero Therapeutics Holdings, Stock Price on November 11, 2024
| CERO Stock | 0.06 0.01 19.00% |
If you're considering investing in CERo Stock, it is important to understand the factors that can impact its price. As of today, the current price of CERo Therapeutics stands at 0.06, as last reported on the 13th of December 2024, with the highest price reaching 0.07 and the lowest price hitting 0.06 during the day. CERo Therapeutics is out of control given 3 months investment horizon. CERo Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0683, which signifies that the company had a 0.0683% return per unit of risk over the last 3 months. We were able to interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.85% are justified by taking the suggested risk. Use CERo Therapeutics risk adjusted performance of 0.0543, and Mean Deviation of 12.15 to evaluate company specific risk that cannot be diversified away.
As of the 13th of December 2024, Common Stock Shares Outstanding is likely to grow to about 9.7 M, though Total Stockholder Equity is likely to grow to (13.5 M). . As of the 13th of December 2024, Price Earnings Ratio is likely to grow to about (26.9 K). In addition to that, Price Book Value Ratio is likely to grow to -4.8. CERo Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
CERo |
Sharpe Ratio = 0.0683
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | CERO | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 27.13 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.85 actual daily | 36 64% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average CERo Therapeutics is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CERo Therapeutics by adding it to a well-diversified portfolio.
Book Value (0.52) | Enterprise Value 12.7 M | Shares Float 46.5 M | Shares Outstanding 51.4 M | Market Capitalization 4.8 M |
CERo Therapeutics Main Headline on 11th of November 2024
CERo Therapeutics Stock Is Soaring Monday Whats Going On by benzinga.com
CERo Therapeutics Holdings, Inc. shares are moving higher Monday after the company presented preclinical data for its lead compound.
CERo Therapeutics Valuation on November 11, 2024
It is possible to determine the worth of CERo Therapeutics on a given historical date. On November 11, 2024 CERo was worth 0.19 at the beginning of the trading date compared to the closed value of 0.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of CERo Therapeutics stock. Still, in general, we apply an absolute valuation method to find CERo Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of CERo Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against CERo Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 0.07 | 0.07 | 0.07 | 0.07 | 2,480,670 | |
11/11/2024 | 0.19 | 0.24 | 0.15 | 0.20 | 1,446,774,900 |
| 0.30 | 0.33 | 0.23 | 0.27 | 770,305,100 |
| Backtest CERo Therapeutics | | | CERo Therapeutics History | | | CERo Therapeutics Valuation | Previous | Next |
CERo Therapeutics Trading Date Momentum on November 11, 2024
| On November 12 2024 CERo Therapeutics Holdings, was traded for 0.27 at the closing time. The top price for the day was 0.33 and the lowest listed price was 0.23 . The trading volume for the day was 770.3 M. The trading history from November 12, 2024 was a factor to the next trading day price boost. The overall trading delta against the next closing price was 35.00% . The overall trading delta against the current closing price is 20.00% . |
CERo Therapeutics Fundamentals Correlations and Trends
By evaluating CERo Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among CERo Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. CERo financial account trend analysis is a perfect complement when working with valuation or volatility modules.About CERo Therapeutics Stock history
CERo Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for CERo is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in CERo Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing CERo Therapeutics stock prices may prove useful in developing a viable investing in CERo Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 6.5 M | 9.7 M |
CERo Therapeutics Stock Technical Analysis
CERo Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
CERo Therapeutics Period Price Range
Low | December 13, 2024
| High |
0.00 | 0.00 |
CERo Therapeutics Holdings, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
CERo Therapeutics December 13, 2024 Market Strength
Market strength indicators help investors to evaluate how CERo Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading CERo Therapeutics shares will generate the highest return on investment. By undertsting and applying CERo Therapeutics stock market strength indicators, traders can identify CERo Therapeutics Holdings, entry and exit signals to maximize returns
CERo Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for CERo Therapeutics' price direction in advance. Along with the technical and fundamental analysis of CERo Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of CERo to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0543 | |||
| Jensen Alpha | 1.56 | |||
| Total Risk Alpha | (2.10) | |||
| Sortino Ratio | 0.1328 | |||
| Treynor Ratio | 2.73 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CERo Therapeutics Holdings,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CERo Therapeutics. If investors know CERo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CERo Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.19) | Return On Assets (0.45) |
The market value of CERo Therapeutics is measured differently than its book value, which is the value of CERo that is recorded on the company's balance sheet. Investors also form their own opinion of CERo Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is CERo Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CERo Therapeutics' market value can be influenced by many factors that don't directly affect CERo Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CERo Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if CERo Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CERo Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.